3-iodobenzylguanidine has been researched along with Mood Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, S; Bokura, H; Kohno, N; Oguro, H; Toyoda, G; Yamaguchi, S | 1 |
| Becker, G; Benecke, R; Braune, S; Büttner, T; Greulich, W; Klein, W; Mark, G; Müller, A; Rieke, J; Thümler, R | 1 |
1 review(s) available for 3-iodobenzylguanidine and Mood Disorders
| Article | Year |
|---|---|
Early diagnosis of Parkinson's disease.
Topics: 3-Iodobenzylguanidine; Affect; Biomarkers; Handwriting; Heart; Humans; Iron; Mood Disorders; Movement Disorders; Mutation; Olfaction Disorders; Parkinson Disease; Peripheral Nervous System Diseases; Psychomotor Performance; Radiopharmaceuticals; Risk Assessment; Risk Factors; Speech; Substantia Nigra; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ultrasonography; Vision, Ocular | 2002 |
1 other study(ies) available for 3-iodobenzylguanidine and Mood Disorders
| Article | Year |
|---|---|
Successful treatment of post-stroke apathy by the dopamine receptor agonist ropinirole.
Topics: 3-Iodobenzylguanidine; Aged, 80 and over; Brain; Diffusion Magnetic Resonance Imaging; Dopamine Agonists; Humans; Indoles; Male; Mood Disorders; Radionuclide Imaging; Stroke | 2010 |